Summary
Signal counts
Assets tracked: 2
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
BioAtla, .
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT04681131 | https://clinicaltrials.gov/study/NCT03425279 | https://clinicaltrials.gov/study/NCT03504488
Assets
Linked programs
- CAB-AXL-ADC: Results Not Found Signal (2/5)
- CAB-ROR2-ADC: Results Not Found Signal (2/5)